XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Common Class A [Member]
Retained Earnings [Member]
Common Class B [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Common Class A [Member]
Parent [Member]
Common Class B [Member]
Parent [Member]
Noncontrolling Interest [Member]
Common Class A [Member]
Common Class B [Member]
Total
Balance (in shares) 63,518 18,125                            
Balance     $ 572,000 $ 500,642,000 $ (130,930,000)     $ 1,378,337,000 $ (4,130,000)     $ 1,744,491,000 $ 18,531,000     $ 1,763,022,000
Balance (in shares) at Dec. 31, 2022 63,518 18,125                            
Balance at Dec. 31, 2022     572,000 500,642,000 (130,930,000)     1,378,337,000 (4,130,000)     1,744,491,000 18,531,000     1,763,022,000
Stock options exercised and stock awards (in shares) 228                              
Stock options exercised and stock awards     2,000 3,412,000               3,414,000       3,414,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       13,080,000               13,080,000        
Vesting of restricted share awards (in shares)   422                            
Vesting of restricted share awards     3,000 (6,964,000)               (6,961,000)       (6,961,000)
Issuance of common stock under employee stock purchase plan (in shares) 102                              
Issuance of common stock under employee stock purchase plan       2,828,000               2,828,000       2,828,000
Common stock repurchases (in shares) (623) (84)                            
Common stock repurchases         (25,280,000)             (25,280,000)       (25,280,000)
Cash dividends declared           $ (8,897,000) $ (2,692,000)     $ (8,897,000) $ (2,692,000)          
Foreign currency translation adjustment                 232,000     232,000        
Net income               90,455,000       90,455,000 335,000      
Foreign currency translation                 232,000     232,000        
Balance (in shares) at Mar. 31, 2023 63,225 18,463                            
Balance at Mar. 31, 2023     577,000 512,998,000 (156,210,000)     1,457,203,000 (3,898,000)     1,810,670,000 18,866,000     1,829,536,000
Balance (in shares) at Dec. 31, 2022 63,518 18,125                            
Balance at Dec. 31, 2022     572,000 500,642,000 (130,930,000)     1,378,337,000 (4,130,000)     1,744,491,000 18,531,000     1,763,022,000
Foreign currency translation adjustment                               1,921,000
Net income                               189,314,000
Foreign currency translation                               1,921,000
Balance (in shares) at Jun. 30, 2023 62,572 18,269                            
Balance at Jun. 30, 2023     578,000 522,375,000 (196,515,000)     1,543,941,000 (2,209,000)     1,868,170,000 19,115,000     1,887,285,000
Balance (in shares) 63,225 18,463                            
Balance     577,000 512,998,000 (156,210,000)     1,457,203,000 (3,898,000)     1,810,670,000 18,866,000     1,829,536,000
Balance (in shares) at Mar. 31, 2023 63,225 18,463                            
Balance at Mar. 31, 2023     577,000 512,998,000 (156,210,000)     1,457,203,000 (3,898,000)     1,810,670,000 18,866,000     1,829,536,000
Stock options exercised and stock awards (in shares) 237                              
Stock options exercised and stock awards     1,000 3,479,000               3,480,000       3,480,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       5,952,000               5,952,000       5,952,000
Vesting of restricted share awards       (54,000)               (54,000)       (54,000)
Common stock repurchases         (40,305,000)             (40,305,000)       (40,305,000)
Cash dividends declared           (8,812,000) (2,725,000)     (8,812,000) (2,725,000)     $ (8,812,000) $ (2,725,000)  
Foreign currency translation adjustment                 1,689,000     1,689,000       1,689,000
Net income               98,275,000       98,275,000 249,000     98,524,000
Foreign currency translation                 1,689,000     1,689,000       1,689,000
Balance (in shares) at Jun. 30, 2023 62,572 18,269                            
Balance at Jun. 30, 2023     578,000 522,375,000 (196,515,000)     1,543,941,000 (2,209,000)     1,868,170,000 19,115,000     1,887,285,000
Balance (in shares) 62,572 18,269                            
Balance     578,000 522,375,000 (196,515,000)     1,543,941,000 (2,209,000)     1,868,170,000 19,115,000     1,887,285,000
Balance (in shares) 61,461 16,364                            
Balance     806,000 542,046,000 (119,835,000)     1,450,025,000 (2,163,000)     1,870,879,000       1,890,416,000
Balance (in shares) at Dec. 31, 2023 61,461 16,364                            
Balance at Dec. 31, 2023     806,000 542,046,000 (119,835,000)     1,450,025,000 (2,163,000)     1,870,879,000       1,890,416,000
Stock options exercised and stock awards (in shares) 383                              
Stock options exercised and stock awards     4,000 5,997,000               6,001,000       6,001,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       14,090,000               14,090,000       14,090,000
Vesting of restricted share awards (in shares)   351                            
Vesting of restricted share awards     4,000 (9,486,000)               (9,482,000)       (9,482,000)
Issuance of common stock under employee stock purchase plan (in shares) 97                              
Issuance of common stock under employee stock purchase plan     1,000 3,354,000               3,355,000       3,355
Common stock repurchases (in shares) (128)                              
Common stock repurchases         (5,627,000)             (5,627,000)       (5,627,000)
Cash dividends declared           (10,467,000) (2,964,000)     (10,467,000) (2,964,000)     (10,467,000) (2,964,000)  
Foreign currency translation adjustment                 (1,891,000)     (1,891,000)       (1,891,000)
Net income               71,608,000       71,608,000 (119,000)     71,489,000
Foreign currency translation                 (1,891,000)     (1,891,000)       (1,891,000)
Balance (in shares) at Mar. 31, 2024 61,813 16,715                            
Balance at Mar. 31, 2024     815,000 556,001,000 (125,462,000)     1,508,202,000 (4,054,000)     1,935,502,000 19,418,000     1,954,920,000
Balance (in shares) at Dec. 31, 2023 61,461 16,364                            
Balance at Dec. 31, 2023     806,000 542,046,000 (119,835,000)     1,450,025,000 (2,163,000)     1,870,879,000       1,890,416,000
Foreign currency translation adjustment                               (2,764,000)
Net income                               150,272,000
Foreign currency translation                               (2,764,000)
Balance (in shares) at Jun. 30, 2024 61,869 16,700                            
Balance at Jun. 30, 2024     816,000 563,604,000 (129,415,000)     1,573,316,000 (4,927,000)     2,003,394,000 19,540,000     2,022,934,000
Balance (in shares) 61,813 16,715                            
Balance     815,000 556,001,000 (125,462,000)     1,508,202,000 (4,054,000)     1,935,502,000 19,418,000     1,954,920,000
Balance (in shares) at Mar. 31, 2024 61,813 16,715                            
Balance at Mar. 31, 2024     815,000 556,001,000 (125,462,000)     1,508,202,000 (4,054,000)     1,935,502,000 19,418,000     1,954,920,000
Stock options exercised and stock awards (in shares) 134                              
Stock options exercised and stock awards     1,000 2,098,000               2,099,000       2,099,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       5,515,000               5,515,000       5,515,000
Vesting of restricted share awards       (10,000)               (10,000)       (10,000)
Common stock repurchases (in shares) (78) (15)                            
Common stock repurchases         (3,953,000)             (3,953,000)       (3,953,000)
Cash dividends declared           $ (10,523,000) $ (3,024,000)     $ (10,523,000) $ (3,024,000)     $ (10,523,000) $ (3,024,000)  
Foreign currency translation adjustment                 (873,000)     (873,000)       (873,000)
Net income               78,661,000       78,661,000 122,000     78,783,000
Foreign currency translation                 (873,000)     (873,000)       (873,000)
Balance (in shares) at Jun. 30, 2024 61,869 16,700                            
Balance at Jun. 30, 2024     816,000 563,604,000 (129,415,000)     1,573,316,000 (4,927,000)     2,003,394,000 19,540,000     2,022,934,000
Balance (in shares) 61,869 16,700                            
Balance     $ 816,000 $ 563,604,000 $ (129,415,000)     $ 1,573,316,000 $ (4,927,000)     $ 2,003,394,000 $ 19,540,000     $ 2,022,934,000